Ouafik L - Search Results

1

Cytidine deaminase status as a marker of response to azacytidine treatment in MDS and AML patients.

Donnette M, Hamimed M, Ciccolini J, Sicard G, Correard F, Farnault L, Ouafik L, Venton G, Fanciullino R. Donnette M, et al. Among authors: ouafik l. Br J Haematol. 2023 Nov;203(4):625-636. doi: 10.1111/bjh.19096. Epub 2023 Sep 10. Br J Haematol. 2023. PMID: 37691342

2

Determination of 5-azacitidine in human plasma by LC-MS/MS: application to pharmacokinetics pilot study in MDS/AML patients.

Donnette M, Osanno L, Giocanti M, Venton G, Farnault L, Berda-Haddad Y, Costello R, Caroline S, Ouafik L', Ciccolini J, Fanciullino R. Donnette M, et al. Among authors: ouafik l. Cancer Chemother Pharmacol. 2023 Mar;91(3):231-238. doi: 10.1007/s00280-023-04505-y. Epub 2023 Mar 1. Cancer Chemother Pharmacol. 2023. PMID: 36859512

3

Impact of Molecular Biology in Diagnosis, Prognosis, and Therapeutic Management of BCR::ABL1-Negative Myeloproliferative Neoplasm.

Abbou N, Piazzola P, Gabert J, Ernest V, Arcani R, Couderc AL, Tichadou A, Roche P, Farnault L, Colle J, Ouafik L, Morange P, Costello R, Venton G. Abbou N, et al. Among authors: ouafik l. Cells. 2022 Dec 27;12(1):105. doi: 10.3390/cells12010105. Cells. 2022. PMID: 36611899 Free PMC article. Review.

4

Performance and cost efficiency of KRAS mutation testing for metastatic colorectal cancer in routine diagnosis: the MOKAECM study, a nationwide experience.

Blons H, Rouleau E, Charrier N, Chatellier G, Côté JF, Pages JC, de Fraipont F, Boyer JC, Merlio JP, Morel A, Gorisse MC, de Cremoux P, Leroy K, Milano G, Ouafik L, Merlin JL, Le Corre D, Aucouturier P, Sabourin JC, Nowak F, Frebourg T, Emile JF, Durand-Zaleski I, Laurent-Puig P; MOKAECM Collaborative Group. Blons H, et al. Among authors: ouafik l. PLoS One. 2013 Jul 25;8(7):e68945. doi: 10.1371/journal.pone.0068945. Print 2013. PLoS One. 2013. PMID: 23935912 Free PMC article.

5

Cytological Samples: An Asset for the Diagnosis and Therapeutic Management of Patients with Lung Cancer.

Frankel D, Nanni I, Ouafik L, Greillier L, Dutau H, Astoul P, Daniel L, Kaspi E, Roll P. Frankel D, et al. Among authors: ouafik l. Cells. 2023 Feb 27;12(5):754. doi: 10.3390/cells12050754. Cells. 2023. PMID: 36899890 Free PMC article.

6

Extreme Gradient Boosting Tuned with Metaheuristic Algorithms for Predicting Myeloid NGS Onco-Somatic Variant Pathogenicity.

Pellegrino E, Camilla C, Abbou N, Beaufils N, Pissier C, Gabert J, Nanni-Metellus I, Ouafik L. Pellegrino E, et al. Among authors: ouafik l. Bioengineering (Basel). 2023 Jun 23;10(7):753. doi: 10.3390/bioengineering10070753. Bioengineering (Basel). 2023. PMID: 37508780 Free PMC article.

7

Adrenomedullin Secreted by Melanoma Cells Promotes Melanoma Tumor Growth through Angiogenesis and Lymphangiogenesis.

Benyahia Z, Gaudy-Marqueste C, Berenguer-Daizé C, Chabane N, Dussault N, Cayol M, Vellutini C, Djemli A, Nanni I, Beaufils N, Mabrouk K, Grob JJ, Ouafik L. Benyahia Z, et al. Among authors: ouafik l. Cancers (Basel). 2022 Nov 29;14(23):5909. doi: 10.3390/cancers14235909. Cancers (Basel). 2022. PMID: 36497391 Free PMC article.

8

Comparison between Immunocytochemistry, FISH and NGS for ALK and ROS1 Rearrangement Detection in Cytological Samples.

Frankel D, Nanni I, Ouafik L, Camilla C, Pellegrino E, Beaufils N, Greillier L, Dutau H, Astoul P, Kaspi E, Roll P. Frankel D, et al. Among authors: ouafik l. Int J Mol Sci. 2022 Sep 12;23(18):10556. doi: 10.3390/ijms231810556. Int J Mol Sci. 2022. PMID: 36142468 Free PMC article.

9

Plasmatic MMP9 released from tumor-infiltrating neutrophils is predictive for bevacizumab efficacy in glioblastoma patients: an AVAglio ancillary study.

Jiguet-Jiglaire C, Boissonneau S, Denicolai E, Hein V, Lasseur R, Garcia J, Romain S, Appay R, Graillon T, Mason W, Carpentier AF, Brandes AA, Ouafik L', Wick W, Baaziz A, Gigan JP, Argüello RJ, Figarella-Branger D, Chinot O, Tabouret E. Jiguet-Jiglaire C, et al. Among authors: ouafik l. Acta Neuropathol Commun. 2022 Jan 3;10(1):1. doi: 10.1186/s40478-021-01305-4. Acta Neuropathol Commun. 2022. PMID: 34980260 Free PMC article.

10

[BRAF mutation evolution in melanoma: Myth or reality?].

Molines E, Haffner A, Fina F, Malissen N, Ouafik L, Grob JJ, Macagno N. Molines E, et al. Among authors: ouafik l. Ann Pathol. 2022 Mar;42(2):113-118. doi: 10.1016/j.annpat.2021.11.001. Epub 2021 Dec 2. Ann Pathol. 2022. PMID: 34865880 French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

162 results

Search Page